In this study we developed an in vitro bladder cancer model to study if COX-2 inhibitors can modulate tumor resistance to MMC by interfering with the activity of membrane transporter proteins of the ABC family. The gene discussed is ABCB6; the disease is urinary bladder carcinoma.